BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
8.0350
10-一月-25 09:40:41
15 分钟延时
股票
-0.0150
-0.19%
今日范围
8.0349 - 8.4900
ISIN
N/A
来源
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
01 6月 2022 07:00:15 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
06 5月 2022 07:00:28 条件 Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
05 5月 2022 07:00:11 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5月 2022 16:15:39 条件 Nasdaq GlobeNewswire
-
27 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 4月 2022 07:00:52 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 4月 2022 08:30:49 条件 Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 4月 2022 09:15:13 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4月 2022 07:15:42 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire